SBIR/STTR Research Award
Evaluation of a Mobile Application for Patients and Clinical Decision-making Support Tools for Prescribers to Decrease Opioid Misuse and Habit-forming Behaviors Following Post-operative Prescription
Award amount
$1,440,417Program and phase
SBIR · Phase II – Direct to Phase IIAward year
2022Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CONTINUOUS PRECISION MEDICINE INC
- Proposal award date
- 2022-05-01
- Contract end date
- 2024-04-30
- UEI
- HQZMNYMNLV83
- Solicitation number
- DA19-019
- Topic code
- NIDA
Research abstract
PROJECT SUMMARY/ABSTRACTOpioid misuse is an epidemic and a public health crisis. At least 2 million people have an opioid use
disorder (OUD) involving prescription opioids, and 600,000 have heroin OUD6. Alarmingly, 80% of heroin users
used prescription opioids before transitioning to heroin7. It is therefore critical to ensure that opioid pain
therapies are administered safely, in a way that minimizes the potential for aberrant drug related behaviors.
This necessitates individualized opioid regimens and strict adherence, enabling effective pain control without
producing euphoria or withdrawals, both of which can lead to drug seeking behaviors. Continuous Precision
Medicine (CPM) aims to develop a software ecosystem to reduce opioid misuse and over-prescription
in postoperative patients. In a self-funded Phase I, we have developed clinical decision support software,
which consists of a server for data management and analytics and a mobile client application for the patient.
The digital platform delivers a personalized schedule, records dosing and pain levels, and motivates
adherence to dosing by scoring compliance. In this project, we propose to evaluate and improve the CPM suite
of clinical decision support tools and provide clinicians and patients with immediately actionable information to
decrease over-prescription and misuse of opioids during the post-operative period. In the proposed Phase II
SBIR project, CPM will refine and evaluate the mobile application, deploy and test a Prescriber Portal with
dashboard functions to enable physicians to overlay pharmacokinetic and pharmacodynamic modeling to
improve prescribing practices and deter drug-habit-forming behavior, and prepare materials for a 501(k)
application submission. The CPM app, patient data, and provider portal, taken together and optimally
employed to improve patient-provider communication and treatment planning, has the potential to prevent
negative sequelae associated with over-prescription and misuse of opioids, including opioid use
disorder, overdose, and death.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)